家族性高胆固醇血症
低密度脂蛋白受体
错义突变
高脂血症
表型
疾病
生物信息学
基因
PCSK9
编码(社会科学)
限制
维加维斯
医学
遗传变异
生物
编码区
遗传学
低密度脂蛋白胆固醇
计算生物学
突变
动脉粥样硬化性心血管疾病
胆固醇
冠状动脉疾病
临床表型
候选基因
功能基因组学
基因组学
脂蛋白
作者
Daniel Tabet,Atina G. Coté,Megan Lancaster,Jochen Weile,Ashyad Rayhan,Iosifina Fotiadou,Nishka Kishore,Roujia Li,Da Kuang,Jennifer J. Knapp,Carmela Serio Carrero,Olivia Taverniti,Anna Axakova,Jack M.P. Castelli,Mohammad Majharul Islam,Shahin Sowlati‐Hashjin,Aanshi Gandhi,Ranim Maaieh,Michael Garton,Kenneth A. Matreyek
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2025-10-30
卷期号:391 (6787): eady7186-eady7186
被引量:17
标识
DOI:10.1126/science.ady7186
摘要
Variants in the familial hypercholesterolemia gene LDLR —the most important genetic driver of cardiovascular disease—can raise circulating low-density lipoprotein (LDL) cholesterol concentrations and increase the risk of premature atherosclerosis. Definitive classifications are lacking for nearly half of clinically encountered LDLR missense variants, limiting interventions that reduce disease burden. We tested the impact of ~17,000 (nearly all possible) LDLR coding variants on both LDLR cell-surface abundance and LDL uptake, yielding sequence–function maps that recapitulate known biochemistry, offer functional insights, and provide evidence for interpreting clinical variants. Functional scores correlated with hyperlipidemia phenotypes in prospective human cohorts and augmented polygenic scores to improve risk inference, highlighting the potential of this resource to accelerate familial hypercholesterolemia diagnosis and improve patient outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI